Jan Hoflack

Fundador en ONCODESIGN PRECISION MEDICINE .

66 años

Health Technology

Commercial Services

Consumer Services

Perfil

Jan Hoflack is the founder of Pharmopsis BV, founded in 2010, where the title held was Deputy Chief Executive Officer.
Dr. Hoflack is the founder of Oncodesign Precision Medicine SA, founded in 2020, holding the titles of Director, Chief Scientific Officer & Deputy MD.
The current job is Chief Scientific Officer & General Manager at Oncodesign SA, starting in 2009.
Former jobs include External Director at GNI Group Ltd. and Vice President-Medicinal Chemistry at Johnson & Johnson Pharmaceutical Research & Development LLC.
Education includes a doctorate from Ghent University.

Cargos activos de Jan Hoflack

Empresas	Cargo	Inicio
ONCODESIGN	Director Técnico/Científico/I+D	-
ONCODESIGN PRECISION MEDICINE	Fundador	15/12/2020

Todos los cargos activos de Jan Hoflack

Antiguos cargos conocidos de Jan Hoflack.

Empresas	Cargo	Fin
Pharmopsis BV	Fundador	-
Johnson & Johnson Pharmaceutical Research & Development LLC Johnson & Johnson Pharmaceutical Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Provides providing research and development support services	Corporate Officer/Principal	-
GNI GROUP LTD.	Director/Miembro de la Junta	-

Ver el detalle de la experiencia de Jan Hoflack.

Formación de Jan Hoflack.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Jan Hoflack.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	6
Johnson & Johnson Pharmaceutical Research & Development LLC Johnson & Johnson Pharmaceutical Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Provides providing research and development support services	Commercial Services
Ghent University Ghent University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Oncodesign SA Oncodesign SA BiotechnologyHealth Technology Develops preclinical evaluation of novel anticancer therapies	Health Technology
GNI Group Ltd. GNI Group Ltd. BiotechnologyHealth Technology Engages in research and development, manufacture and sale of pharmaceutical products	Health Technology
Pharmopsis BV
Oncodesign Precision Medicine SA Oncodesign Precision Medicine SA Pharmaceuticals: MajorHealth Technology Discovers and develops new molecules for the health treatments in oncology	Health Technology